225 related articles for article (PubMed ID: 26821215)
1. NOS1 and SNAP25 polymorphisms are associated with Attention-Deficit/Hyperactivity Disorder symptoms in adults but not in children.
Salatino-Oliveira A; Akutagava-Martins GC; Bruxel EM; Genro JP; Polanczyk GV; Zeni C; Kieling C; Karam RG; Rovaris DL; Contini V; Cupertino RB; Mota NR; Grevet EH; Bau CH; Rohde LA; Hutz MH
J Psychiatr Res; 2016 Apr; 75():75-81. PubMed ID: 26821215
[TBL] [Abstract][Full Text] [Related]
2. MAP1B and NOS1 genes are associated with working memory in youths with attention-deficit/hyperactivity disorder.
Salatino-Oliveira A; Wagner F; Akutagava-Martins GC; Bruxel EM; Genro JP; Zeni C; Kieling C; Polanczyk GV; Rohde LA; Hutz MH
Eur Arch Psychiatry Clin Neurosci; 2016 Jun; 266(4):359-66. PubMed ID: 26233433
[TBL] [Abstract][Full Text] [Related]
3. Association study of GIT1 gene with attention-deficit hyperactivity disorder in Brazilian children and adolescents.
Salatino-Oliveira A; Genro JP; Chazan R; Zeni C; Schmitz M; Polanczyk G; Roman T; Rohde LA; Hutz MH
Genes Brain Behav; 2012 Oct; 11(7):864-8. PubMed ID: 22897819
[TBL] [Abstract][Full Text] [Related]
4. Nitric oxide synthase genotype modulation of impulsivity and ventral striatal activity in adult ADHD patients and healthy comparison subjects.
Hoogman M; Aarts E; Zwiers M; Slaats-Willemse D; Naber M; Onnink M; Cools R; Kan C; Buitelaar J; Franke B
Am J Psychiatry; 2011 Oct; 168(10):1099-106. PubMed ID: 21724667
[TBL] [Abstract][Full Text] [Related]
5. Female-specific association of NOS1 genotype with white matter microstructure in ADHD patients and controls.
van Ewijk H; Bralten J; van Duin EDA; Hakobjan M; Buitelaar JK; Heslenfeld DJ; Hoekstra PJ; Hartman C; Hoogman M; Oosterlaan J; Franke B
J Child Psychol Psychiatry; 2017 Aug; 58(8):958-966. PubMed ID: 28589541
[TBL] [Abstract][Full Text] [Related]
6. The relationship between the presence of ADHD and certain candidate gene polymorphisms in a Turkish sample.
Pazvantoğlu O; Güneş S; Karabekiroğlu K; Yeğin Z; Erenkuş Z; Akbaş S; Sarısoy G; Korkmaz IZ; Böke O; Bağcı H; Sahin AR
Gene; 2013 Oct; 528(2):320-7. PubMed ID: 23872233
[TBL] [Abstract][Full Text] [Related]
7. [Effects of Nitric Oxide Synthase-1 Exon 1f-VNTR Gene Polymorphism on the Clinical Symptoms of Alcohol Dependence,Impulsivity and Comorbid Attention Deficit Hyperactivity Disorder].
Karakaya İ; Gürel ŞC; Ayhan Y; Kaşifoğlu MA; Karahan S; Babaoğlu MÖ; Göka E; Dilbaz HN; Uluğ BD; Demir B
Turk Psikiyatri Derg; 2019; 30(2):82-89. PubMed ID: 31487373
[TBL] [Abstract][Full Text] [Related]
8. The Association of SNAP25 Gene Polymorphisms in Attention Deficit/Hyperactivity Disorder: a Systematic Review and Meta-Analysis.
Liu YS; Dai X; Wu W; Yuan FF; Gu X; Chen JG; Zhu LQ; Wu J
Mol Neurobiol; 2017 Apr; 54(3):2189-2200. PubMed ID: 26941099
[TBL] [Abstract][Full Text] [Related]
9. Influence of functional variant of neuronal nitric oxide synthase on impulsive behaviors in humans.
Reif A; Jacob CP; Rujescu D; Herterich S; Lang S; Gutknecht L; Baehne CG; Strobel A; Freitag CM; Giegling I; Romanos M; Hartmann A; Rösler M; Renner TJ; Fallgatter AJ; Retz W; Ehlis AC; Lesch KP
Arch Gen Psychiatry; 2009 Jan; 66(1):41-50. PubMed ID: 19124687
[TBL] [Abstract][Full Text] [Related]
10. Association of the adrenergic alpha2A receptor gene with methylphenidate improvement of inattentive symptoms in children and adolescents with attention-deficit/hyperactivity disorder.
Polanczyk G; Zeni C; Genro JP; Guimarães AP; Roman T; Hutz MH; Rohde LA
Arch Gen Psychiatry; 2007 Feb; 64(2):218-24. PubMed ID: 17283289
[TBL] [Abstract][Full Text] [Related]
11. Relationship between the SNAP-25 gene and the effects of methylphenidate on the anterior cingulate cortex of patients with adult attention deficit hyperactivity disorder: a magnetic resonance spectroscopy study.
Ünal GA; İnci Kenar AN; Tepeli E; Kıroğlu Y; Herken H
Eur Rev Med Pharmacol Sci; 2016 Jun; 20(11):2443-9. PubMed ID: 27338073
[TBL] [Abstract][Full Text] [Related]
12. Atomoxetine versus placebo in children and adolescents with attention-deficit/hyperactivity disorder and comorbid oppositional defiant disorder: a double-blind, randomized, multicenter trial in Germany.
Dittmann RW; Schacht A; Helsberg K; Schneider-Fresenius C; Lehmann M; Lehmkuhl G; Wehmeier PM
J Child Adolesc Psychopharmacol; 2011 Apr; 21(2):97-110. PubMed ID: 21488751
[TBL] [Abstract][Full Text] [Related]
13. Evidence of association between SNAP25 gene and attention deficit hyperactivity disorder in a Latin American sample.
Gálvez JM; Forero DA; Fonseca DJ; Mateus HE; Talero-Gutierrez C; Velez-van-Meerbeke A
Atten Defic Hyperact Disord; 2014 Mar; 6(1):19-23. PubMed ID: 24362847
[TBL] [Abstract][Full Text] [Related]
14. The SNAP25 gene as a susceptibility gene contributing to attention-deficit hyperactivity disorder.
Feng Y; Crosbie J; Wigg K; Pathare T; Ickowicz A; Schachar R; Tannock R; Roberts W; Malone M; Swanson J; Kennedy JL; Barr CL
Mol Psychiatry; 2005 Nov; 10(11):998-1005, 973. PubMed ID: 16088329
[TBL] [Abstract][Full Text] [Related]
15. Catechol-O-methyltransferase valine158methionine polymorphism moderates methylphenidate effects on oppositional symptoms in boys with attention-deficit/hyperactivity disorder.
Salatino-Oliveira A; Genro JP; Zeni C; Polanczyk GV; Chazan R; Guimarães AP; Callegari-Jacques SM; Rohde LA; Hutz MH
Biol Psychiatry; 2011 Aug; 70(3):216-21. PubMed ID: 21550019
[TBL] [Abstract][Full Text] [Related]
16. [Association between SNAP-25 gene polymorphism and attention deficit hyperactivity disorder].
Zhang HY; Zhu YB; Chang H; Chen JC
Zhonghua Er Ke Za Zhi; 2008 Aug; 46(8):564-9. PubMed ID: 19099826
[TBL] [Abstract][Full Text] [Related]
17. Psychometric properties of the Sinhala version of the Swanson, Nolan, and Pelham rating scale (SNAP-IV) Parent Form in healthy children and children with ADHD.
Abhayaratna HC; Ariyasinghe DI; Ginige P; Chandradasa M; Hansika KS; Fernando A; Wijetunge S; Dassanayake TL
Asian J Psychiatr; 2023 May; 83():103542. PubMed ID: 36963301
[TBL] [Abstract][Full Text] [Related]
18. GAD1 gene polymorphisms are associated with hyperactivity in Attention-Deficit/Hyperactivity Disorder.
Bruxel EM; Akutagava-Martins GC; Salatino-Oliveira A; Genro JP; Zeni CP; Polanczyk GV; Chazan R; Schmitz M; Rohde LA; Hutz MH
Am J Med Genet B Neuropsychiatr Genet; 2016 Dec; 171(8):1099-1104. PubMed ID: 27530595
[TBL] [Abstract][Full Text] [Related]
19. [Association of 14 polymorphisms in the five candidate genes and attention deficit hyperactivity disorder].
Gao XP; Su LY; Zhao AL; Luo XR; Xia K
Zhongguo Dang Dai Er Ke Za Zhi; 2009 Aug; 11(8):617-22. PubMed ID: 19695183
[TBL] [Abstract][Full Text] [Related]
20. An Open-Label, Randomized Trial of Methylphenidate and Atomoxetine Treatment in Children with Attention-Deficit/Hyperactivity Disorder.
Shang CY; Pan YL; Lin HY; Huang LW; Gau SS
J Child Adolesc Psychopharmacol; 2015 Sep; 25(7):566-73. PubMed ID: 26222447
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
